About the Tri-State Trek

The Tri-State trek enables me to help Pete Frates accomplish his goal of spreading awareness for this disease and help fund a cure. This was the core of my motivation to do my first trek. Meeting other riders, the doctors, the volunteers... Hearing stories of the family members of folks battling ALS or have lost their battle is all what keeps me riding. I'm so fortunate to be able to participate in this event, to ride a bike, to meet the other people in pursuit of a cure, and continue Pete's mission. Thank you ALS TDI for creating the opportunity for me to give back.

Andrew Ruggiero

The ALS TDI Tri-State Trek raises money and brings attention to the work ALS TDI is doing to find an effective treatment for a horrific disease.

The Trek began in 2003, when 16 cyclists pedaled from Boston to New York and raised about $30k for ALS research. The event has since grown to over 400 participants, raising over 7 million dollars. People ride, crew or volunteer to support changes in medical science. Riders gain strength from spectators cheering them on with cowbells, letting them know they are not alone on their bikes.

We Need More Cowbell!

In 2005, in an effort to bolster spectator support, Interns for the Trek passed out cowbells in White Plains, NY, (the Trek's former finish line) as part of a community outreach project. In 2006, the event officially launched its 'More Cowbell!' campaign; a knock-off on the pop-culture catch phrase originally delivered by Christopher Walken in a well known Saturday Night Live skit. Cowbells have been used in cycling since the early 1900s, when European's would cheer riders racing through the Pyrenees or up the Italian Alps.

For the cyclists, volunteers, and countless spectators and supporters, "More Cowbell!" is about more noise and more support for an orphaned disease and its patients that will not stand silent. Buy your cowbells here!

About the ALS Therapy Development Institute

The ALS Therapy Development Institute and its scientists actively discover and develop treatments for ALS. The Institute is the world's first and largest nonprofit biotech focused 100 percent on ALS research. Led by ALS patients and their families, the charity understands the urgent need to slow and stop this horrible disease. Based in Cambridge, MA, the Institute has served as one of the leaders in sharing data and information with academic and ALS research organizations, patients and their families. For more information, visit www.alstdi.org.

About ALS

Every 90 minutes, someone is diagnosed with amyotrophic lateral sclerosis (ALS); a progressive, neurodegenerative disease that causes muscle weakness, difficulty breathing and swallowing, and paralysis while leaving the senses intact. Also known as Lou Gehrig's disease or Motor Neuron Disease (MND), ALS attacks certain cells in the brain and spinal cord needed to keep muscles moving. Most people survive 2 to 5 years after their diagnosis, with an estimated 30,000 people in the US and 450,000 worldwide living with the disease. Currently, there are no effective treatments or a cure.